HIV drugs for children to be produced under one dollar a day in Sub-Saharan Africa

Kigali, Rwanda (PANA) - The Indian pharmaceutical company, Cipla, on Friday announced their commitment to price the ground-breaking new product Quadrimune, a “4 in 1” treatment for young children with HIV, at below a dollar a day in Sub-Saharan Africa